The earliest signs of Alzheimer’s disease are subtle enough that most people dismiss them as normal aging for months or even years. More than 7 million Americans are currently living with Alzheimer’s, and the disease often isn’t diagnosed until it has already progressed past its mildest stage. Knowing the difference between ordinary forgetfulness and genuine warning signs is the first step toward getting answers.
Normal Aging vs. Early Warning Signs
Everyone forgets things as they get older. Misplacing your car keys, blanking on an acquaintance’s name, or struggling to find a word that comes to you later are all part of normal aging. These lapses are annoying but they don’t disrupt your daily life or get steadily worse over time.
Alzheimer’s looks different. The kinds of memory and thinking changes that raise concern include:
- Getting lost in familiar places, like your own neighborhood or a route you’ve driven for years
- Forgetting close people’s names, not just acquaintances but family members or longtime friends
- Losing older memories, not just recent events but things that happened years ago
- Using unusual words for everyday objects, like calling a watch a “hand clock” because the real word won’t come
- Struggling to complete routine tasks independently, such as cooking a familiar recipe, paying bills, or following directions you’ve used before
The key distinction isn’t whether you forget something. It’s whether the forgetting is getting worse, whether it’s affecting your ability to function, and whether you can’t recover the lost information later. Forgetting where you parked and finding the car after a moment of thought is normal. Forgetting that you drove to the store at all is not.
Personality and Behavior Changes
Memory loss gets the most attention, but Alzheimer’s often shows up first as changes in judgment, mood, or personality. People in early stages may make unusual financial decisions, like giving money to telemarketers or neglecting bills they’ve always paid on time. They may withdraw from hobbies or social activities they used to enjoy, not because of physical limitations but because following conversations or keeping track of a card game has become quietly exhausting.
Asking the same question repeatedly in a single conversation is one of the more recognizable early signs. So is trouble with planning or problem-solving, like becoming overwhelmed by organizing a family dinner that used to feel routine. These changes are often more visible to family members than to the person experiencing them.
Physical Changes That Can Appear Early
Alzheimer’s isn’t just a memory disease. Research published in The Lancet Healthy Longevity found that declining motor function, including changes in walking speed and grip strength, often precedes noticeable cognitive symptoms. In some cases, gait changes appeared more than nine years before death, while measurable cognitive decline showed up closer to six or seven years before death. Walking more slowly, losing your balance more easily, or developing an unsteady gait can be early physical signals that something is changing in the brain, particularly when vascular damage is involved.
This doesn’t mean that slowing down physically guarantees Alzheimer’s. But if you or someone close to you notices both thinking changes and a decline in coordination or walking ability, that combination is worth bringing up with a doctor.
How Alzheimer’s Is Diagnosed
There is no single test that confirms Alzheimer’s on the spot. Diagnosis typically involves several steps, starting with a cognitive assessment your doctor can perform during a regular visit or a dedicated appointment. Medicare covers a separate visit specifically for cognitive evaluation, which includes a medical history review, a functional assessment, and the creation of a care plan if needed.
Two of the most commonly used screening tools are short, office-based tests scored on a 30-point scale. A score of 24 or below on one widely used exam raises concern for possible dementia. On the Montreal Cognitive Assessment, scores between 20 and 25 suggest possible mild cognitive impairment or early dementia, while scores below 20 point more strongly toward dementia. These tests check memory, attention, language, and the ability to perform tasks like drawing a clock or counting backward.
A low score doesn’t automatically mean Alzheimer’s. Depression, medication side effects, thyroid problems, and vitamin deficiencies can all cause similar symptoms. Your doctor will typically rule these out before moving to more specialized testing.
Blood Tests and Brain Scans
Alzheimer’s diagnosis has changed significantly in recent years. The disease is now defined biologically, based on specific protein buildups in the brain, rather than purely on symptoms. Two proteins are central to the disease: amyloid plaques, which begin accumulating as early as 20 years before any symptoms appear, and tau tangles, which spread through the brain in a predictable pattern and track more closely with the onset of noticeable cognitive decline.
Specialized brain scans can detect both of these proteins directly. Amyloid deposits start in the outer layers of the brain, then move to deeper structures. Tau buildup follows its own path, beginning in memory-related areas and gradually spreading outward. The presence of tau on a brain scan tends to correspond more closely to when a person starts experiencing symptoms.
In early 2025, the FDA cleared the first blood test for diagnosing Alzheimer’s disease. The test measures a ratio of specific proteins in the blood that reflect what’s happening in the brain. In clinical studies, 91.7% of people who tested positive on this blood test also had confirmed amyloid buildup on a brain scan or spinal fluid test. Among those who tested negative, 97.3% were confirmed negative by those same methods. This is a major step toward faster, less invasive diagnosis, though current guidelines still recommend these biomarker tests primarily for people who are already showing symptoms rather than for screening healthy individuals.
The Role of Genetics
One gene in particular, APOE4, significantly affects Alzheimer’s risk. Everyone inherits two copies of the APOE gene (one from each parent), and the APOE4 version is the high-risk variant. Carrying two copies of APOE4 brings an estimated 60% chance of developing Alzheimer’s dementia by age 85. A 2024 NIH study found that nearly all people with two APOE4 copies had Alzheimer’s-related brain changes from age 55 onward, compared to roughly half of those without the gene.
Carrying one copy raises your risk to a lesser degree. Having no copies of APOE4 doesn’t make you immune. Genetic testing for APOE4 is available, but knowing your status doesn’t change the diagnostic process or currently qualify you for treatment if you have no symptoms. It’s most useful as context, not as a standalone answer.
How the Disease Progresses
Alzheimer’s moves through stages, though the boundaries between them are blurry rather than sharp. The preclinical stage, when brain changes are happening but no symptoms are present, can last years or even decades. This is followed by mild cognitive impairment, where memory and thinking changes are noticeable but don’t yet interfere with work or relationships.
When the disease reaches the mild dementia stage, the impact becomes clear to both the person and those around them. This is when most people receive a formal diagnosis. Trouble with recent memories, difficulty managing finances, asking the same questions repeatedly, and lapses in judgment are hallmarks of this stage. From diagnosis, people live an average of 3 to 11 years, though some live 20 years or more. The pace of progression varies enormously from person to person.
What to Do if You’re Concerned
If you’re reading this article because you’ve noticed changes in yourself, that self-awareness is actually a useful data point. People in the earliest stages of Alzheimer’s often retain the ability to recognize that something feels off. As the disease progresses, that awareness typically fades, which is why family members often become the first to push for evaluation.
Start by requesting a cognitive assessment through your primary care doctor. You can ask for one during your annual wellness visit or schedule a dedicated appointment. Write down the specific changes you’ve noticed, when they started, and how frequently they occur. Concrete examples (forgetting a grandchild’s name three times in a week, getting lost driving to the grocery store) are far more useful to a clinician than vague concerns about “feeling foggy.”
Early evaluation matters more now than it did even a few years ago. New treatments targeting amyloid protein are available for people in early stages, and they work best when the disease is caught before significant damage has occurred. Getting a clear answer, whether it’s Alzheimer’s, a treatable condition mimicking it, or normal aging, puts you in a position to act on it.